CHICAGO, Aug 1 (Reuters) - The U.S. Food and Drug Administration on Tuesday warned medical device maker Cardiac Science Corp. (CSCX.O: Quote, Profile, Research) that it must correct procedures to ensure the quality of its external heart defibrillators.
